nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—systemic scleroderma—ankylosing spondylitis	0.818	1	CtDrD
Lisinopril—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0315	0.279	CbGbCtD
Lisinopril—ABCB1—Betamethasone—ankylosing spondylitis	0.0205	0.182	CbGbCtD
Lisinopril—ABCB1—Prednisolone—ankylosing spondylitis	0.0202	0.179	CbGbCtD
Lisinopril—ABCB1—Prednisone—ankylosing spondylitis	0.0191	0.169	CbGbCtD
Lisinopril—ABCB1—Dexamethasone—ankylosing spondylitis	0.0119	0.106	CbGbCtD
Lisinopril—ABCB1—Methotrexate—ankylosing spondylitis	0.00957	0.0849	CbGbCtD
Lisinopril—Malaise—Betamethasone—ankylosing spondylitis	0.000103	0.00147	CcSEcCtD
Lisinopril—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000102	0.00147	CcSEcCtD
Lisinopril—Oedema—Triamcinolone—ankylosing spondylitis	0.000102	0.00147	CcSEcCtD
Lisinopril—Vertigo—Dexamethasone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Vertigo—Betamethasone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Syncope—Dexamethasone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Syncope—Betamethasone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Arrhythmia—Prednisone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Infection—Triamcinolone—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Sweating—Methotrexate—ankylosing spondylitis	0.000102	0.00146	CcSEcCtD
Lisinopril—Infection—Methylprednisolone—ankylosing spondylitis	0.000102	0.00145	CcSEcCtD
Lisinopril—Haematuria—Methotrexate—ankylosing spondylitis	0.000101	0.00145	CcSEcCtD
Lisinopril—Shock—Triamcinolone—ankylosing spondylitis	0.000101	0.00144	CcSEcCtD
Lisinopril—Insomnia—Prednisolone—ankylosing spondylitis	0.000101	0.00144	CcSEcCtD
Lisinopril—Alopecia—Prednisone—ankylosing spondylitis	0.000101	0.00144	CcSEcCtD
Lisinopril—Shock—Methylprednisolone—ankylosing spondylitis	0.000101	0.00144	CcSEcCtD
Lisinopril—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.0001	0.00144	CcSEcCtD
Lisinopril—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.0001	0.00143	CcSEcCtD
Lisinopril—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.0001	0.00143	CcSEcCtD
Lisinopril—Epistaxis—Methotrexate—ankylosing spondylitis	0.0001	0.00143	CcSEcCtD
Lisinopril—Paraesthesia—Prednisolone—ankylosing spondylitis	0.0001	0.00143	CcSEcCtD
Lisinopril—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0001	0.00143	CcSEcCtD
Lisinopril—Mental disorder—Prednisone—ankylosing spondylitis	9.98e-05	0.00143	CcSEcCtD
Lisinopril—Tachycardia—Methylprednisolone—ankylosing spondylitis	9.98e-05	0.00143	CcSEcCtD
Lisinopril—Skin disorder—Methylprednisolone—ankylosing spondylitis	9.93e-05	0.00142	CcSEcCtD
Lisinopril—Malnutrition—Prednisone—ankylosing spondylitis	9.92e-05	0.00142	CcSEcCtD
Lisinopril—Erythema—Prednisone—ankylosing spondylitis	9.92e-05	0.00142	CcSEcCtD
Lisinopril—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	9.9e-05	0.00142	CcSEcCtD
Lisinopril—Agranulocytosis—Methotrexate—ankylosing spondylitis	9.9e-05	0.00142	CcSEcCtD
Lisinopril—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	9.88e-05	0.00141	CcSEcCtD
Lisinopril—Myalgia—Betamethasone—ankylosing spondylitis	9.7e-05	0.00139	CcSEcCtD
Lisinopril—Myalgia—Dexamethasone—ankylosing spondylitis	9.7e-05	0.00139	CcSEcCtD
Lisinopril—Anxiety—Betamethasone—ankylosing spondylitis	9.66e-05	0.00138	CcSEcCtD
Lisinopril—Anxiety—Dexamethasone—ankylosing spondylitis	9.66e-05	0.00138	CcSEcCtD
Lisinopril—Discomfort—Betamethasone—ankylosing spondylitis	9.58e-05	0.00137	CcSEcCtD
Lisinopril—Discomfort—Dexamethasone—ankylosing spondylitis	9.58e-05	0.00137	CcSEcCtD
Lisinopril—Hypotension—Methylprednisolone—ankylosing spondylitis	9.55e-05	0.00137	CcSEcCtD
Lisinopril—Pain—Prednisolone—ankylosing spondylitis	9.53e-05	0.00136	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—ankylosing spondylitis	9.52e-05	0.00136	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—ankylosing spondylitis	9.45e-05	0.00135	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—ankylosing spondylitis	9.4e-05	0.00135	CcSEcCtD
Lisinopril—Vision blurred—Prednisone—ankylosing spondylitis	9.35e-05	0.00134	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—ankylosing spondylitis	9.33e-05	0.00134	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	9.33e-05	0.00134	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	9.31e-05	0.00133	CcSEcCtD
Lisinopril—Oedema—Betamethasone—ankylosing spondylitis	9.3e-05	0.00133	CcSEcCtD
Lisinopril—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.3e-05	0.00133	CcSEcCtD
Lisinopril—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.3e-05	0.00133	CcSEcCtD
Lisinopril—Oedema—Dexamethasone—ankylosing spondylitis	9.3e-05	0.00133	CcSEcCtD
Lisinopril—Insomnia—Triamcinolone—ankylosing spondylitis	9.27e-05	0.00133	CcSEcCtD
Lisinopril—Insomnia—Methylprednisolone—ankylosing spondylitis	9.25e-05	0.00132	CcSEcCtD
Lisinopril—Infection—Betamethasone—ankylosing spondylitis	9.23e-05	0.00132	CcSEcCtD
Lisinopril—Infection—Dexamethasone—ankylosing spondylitis	9.23e-05	0.00132	CcSEcCtD
Lisinopril—Ill-defined disorder—Prednisone—ankylosing spondylitis	9.2e-05	0.00132	CcSEcCtD
Lisinopril—Paraesthesia—Triamcinolone—ankylosing spondylitis	9.2e-05	0.00132	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.18e-05	0.00131	CcSEcCtD
Lisinopril—Paraesthesia—Methylprednisolone—ankylosing spondylitis	9.18e-05	0.00131	CcSEcCtD
Lisinopril—Anaemia—Prednisone—ankylosing spondylitis	9.17e-05	0.00131	CcSEcCtD
Lisinopril—Shock—Betamethasone—ankylosing spondylitis	9.15e-05	0.00131	CcSEcCtD
Lisinopril—Shock—Dexamethasone—ankylosing spondylitis	9.15e-05	0.00131	CcSEcCtD
Lisinopril—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.13e-05	0.00131	CcSEcCtD
Lisinopril—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9.1e-05	0.0013	CcSEcCtD
Lisinopril—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9.1e-05	0.0013	CcSEcCtD
Lisinopril—Tachycardia—Dexamethasone—ankylosing spondylitis	9.07e-05	0.0013	CcSEcCtD
Lisinopril—Tachycardia—Betamethasone—ankylosing spondylitis	9.07e-05	0.0013	CcSEcCtD
Lisinopril—Angioedema—Prednisone—ankylosing spondylitis	9.06e-05	0.0013	CcSEcCtD
Lisinopril—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.02e-05	0.00129	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—ankylosing spondylitis	9e-05	0.00129	CcSEcCtD
Lisinopril—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9e-05	0.00129	CcSEcCtD
Lisinopril—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	8.99e-05	0.00129	CcSEcCtD
Lisinopril—Hyperhidrosis—Betamethasone—ankylosing spondylitis	8.99e-05	0.00129	CcSEcCtD
Lisinopril—Malaise—Prednisone—ankylosing spondylitis	8.94e-05	0.00128	CcSEcCtD
Lisinopril—Vertigo—Prednisone—ankylosing spondylitis	8.91e-05	0.00128	CcSEcCtD
Lisinopril—Syncope—Prednisone—ankylosing spondylitis	8.89e-05	0.00127	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—ankylosing spondylitis	8.88e-05	0.00127	CcSEcCtD
Lisinopril—Anorexia—Betamethasone—ankylosing spondylitis	8.86e-05	0.00127	CcSEcCtD
Lisinopril—Anorexia—Dexamethasone—ankylosing spondylitis	8.86e-05	0.00127	CcSEcCtD
Lisinopril—Urticaria—Prednisolone—ankylosing spondylitis	8.85e-05	0.00127	CcSEcCtD
Lisinopril—Fatigue—Triamcinolone—ankylosing spondylitis	8.83e-05	0.00126	CcSEcCtD
Lisinopril—Fatigue—Methylprednisolone—ankylosing spondylitis	8.81e-05	0.00126	CcSEcCtD
Lisinopril—Pain—Triamcinolone—ankylosing spondylitis	8.76e-05	0.00125	CcSEcCtD
Lisinopril—Loss of consciousness—Prednisone—ankylosing spondylitis	8.72e-05	0.00125	CcSEcCtD
Lisinopril—Hypotension—Dexamethasone—ankylosing spondylitis	8.69e-05	0.00124	CcSEcCtD
Lisinopril—Hypotension—Betamethasone—ankylosing spondylitis	8.69e-05	0.00124	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—ankylosing spondylitis	8.64e-05	0.00124	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—ankylosing spondylitis	8.58e-05	0.00123	CcSEcCtD
Lisinopril—Chills—Methotrexate—ankylosing spondylitis	8.54e-05	0.00122	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	8.47e-05	0.00121	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	8.47e-05	0.00121	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—ankylosing spondylitis	8.44e-05	0.00121	CcSEcCtD
Lisinopril—Myalgia—Prednisone—ankylosing spondylitis	8.44e-05	0.00121	CcSEcCtD
Lisinopril—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.44e-05	0.00121	CcSEcCtD
Lisinopril—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.42e-05	0.00121	CcSEcCtD
Lisinopril—Anxiety—Prednisone—ankylosing spondylitis	8.42e-05	0.0012	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—ankylosing spondylitis	8.41e-05	0.0012	CcSEcCtD
Lisinopril—Insomnia—Betamethasone—ankylosing spondylitis	8.41e-05	0.0012	CcSEcCtD
Lisinopril—Insomnia—Dexamethasone—ankylosing spondylitis	8.41e-05	0.0012	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	8.39e-05	0.0012	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	8.36e-05	0.0012	CcSEcCtD
Lisinopril—Paraesthesia—Betamethasone—ankylosing spondylitis	8.35e-05	0.00119	CcSEcCtD
Lisinopril—Paraesthesia—Dexamethasone—ankylosing spondylitis	8.35e-05	0.00119	CcSEcCtD
Lisinopril—Discomfort—Prednisone—ankylosing spondylitis	8.34e-05	0.00119	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—ankylosing spondylitis	8.34e-05	0.00119	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—ankylosing spondylitis	8.29e-05	0.00119	CcSEcCtD
Lisinopril—Erythema—Methotrexate—ankylosing spondylitis	8.29e-05	0.00119	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.21e-05	0.00117	CcSEcCtD
Lisinopril—Dyspepsia—Betamethasone—ankylosing spondylitis	8.18e-05	0.00117	CcSEcCtD
Lisinopril—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.18e-05	0.00117	CcSEcCtD
Lisinopril—Urticaria—Triamcinolone—ankylosing spondylitis	8.14e-05	0.00116	CcSEcCtD
Lisinopril—Urticaria—Methylprednisolone—ankylosing spondylitis	8.12e-05	0.00116	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—ankylosing spondylitis	8.12e-05	0.00116	CcSEcCtD
Lisinopril—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.1e-05	0.00116	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—ankylosing spondylitis	8.1e-05	0.00116	CcSEcCtD
Lisinopril—Oedema—Prednisone—ankylosing spondylitis	8.1e-05	0.00116	CcSEcCtD
Lisinopril—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.08e-05	0.00116	CcSEcCtD
Lisinopril—Decreased appetite—Dexamethasone—ankylosing spondylitis	8.08e-05	0.00116	CcSEcCtD
Lisinopril—Decreased appetite—Betamethasone—ankylosing spondylitis	8.08e-05	0.00116	CcSEcCtD
Lisinopril—Infection—Prednisone—ankylosing spondylitis	8.04e-05	0.00115	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	8.03e-05	0.00115	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	8.03e-05	0.00115	CcSEcCtD
Lisinopril—Back pain—Methotrexate—ankylosing spondylitis	8.02e-05	0.00115	CcSEcCtD
Lisinopril—Fatigue—Betamethasone—ankylosing spondylitis	8.01e-05	0.00115	CcSEcCtD
Lisinopril—Fatigue—Dexamethasone—ankylosing spondylitis	8.01e-05	0.00115	CcSEcCtD
Lisinopril—Shock—Prednisone—ankylosing spondylitis	7.96e-05	0.00114	CcSEcCtD
Lisinopril—Pain—Dexamethasone—ankylosing spondylitis	7.95e-05	0.00114	CcSEcCtD
Lisinopril—Pain—Betamethasone—ankylosing spondylitis	7.95e-05	0.00114	CcSEcCtD
Lisinopril—Tachycardia—Prednisone—ankylosing spondylitis	7.9e-05	0.00113	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—ankylosing spondylitis	7.86e-05	0.00113	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—ankylosing spondylitis	7.83e-05	0.00112	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—ankylosing spondylitis	7.81e-05	0.00112	CcSEcCtD
Lisinopril—Anorexia—Prednisone—ankylosing spondylitis	7.72e-05	0.0011	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—ankylosing spondylitis	7.69e-05	0.0011	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—ankylosing spondylitis	7.66e-05	0.0011	CcSEcCtD
Lisinopril—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.66e-05	0.0011	CcSEcCtD
Lisinopril—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.66e-05	0.0011	CcSEcCtD
Lisinopril—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	7.6e-05	0.00109	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	7.6e-05	0.00109	CcSEcCtD
Lisinopril—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.55e-05	0.00108	CcSEcCtD
Lisinopril—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.53e-05	0.00108	CcSEcCtD
Lisinopril—Malaise—Methotrexate—ankylosing spondylitis	7.48e-05	0.00107	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—ankylosing spondylitis	7.45e-05	0.00107	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—ankylosing spondylitis	7.42e-05	0.00106	CcSEcCtD
Lisinopril—Urticaria—Dexamethasone—ankylosing spondylitis	7.38e-05	0.00106	CcSEcCtD
Lisinopril—Urticaria—Betamethasone—ankylosing spondylitis	7.38e-05	0.00106	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	7.38e-05	0.00106	CcSEcCtD
Lisinopril—Dizziness—Prednisolone—ankylosing spondylitis	7.37e-05	0.00105	CcSEcCtD
Lisinopril—Asthenia—Triamcinolone—ankylosing spondylitis	7.35e-05	0.00105	CcSEcCtD
Lisinopril—Abdominal pain—Betamethasone—ankylosing spondylitis	7.35e-05	0.00105	CcSEcCtD
Lisinopril—Body temperature increased—Betamethasone—ankylosing spondylitis	7.35e-05	0.00105	CcSEcCtD
Lisinopril—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.35e-05	0.00105	CcSEcCtD
Lisinopril—Body temperature increased—Dexamethasone—ankylosing spondylitis	7.35e-05	0.00105	CcSEcCtD
Lisinopril—Asthenia—Methylprednisolone—ankylosing spondylitis	7.33e-05	0.00105	CcSEcCtD
Lisinopril—Insomnia—Prednisone—ankylosing spondylitis	7.32e-05	0.00105	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—ankylosing spondylitis	7.27e-05	0.00104	CcSEcCtD
Lisinopril—Pruritus—Triamcinolone—ankylosing spondylitis	7.25e-05	0.00104	CcSEcCtD
Lisinopril—Cough—Methotrexate—ankylosing spondylitis	7.23e-05	0.00104	CcSEcCtD
Lisinopril—Pruritus—Methylprednisolone—ankylosing spondylitis	7.23e-05	0.00104	CcSEcCtD
Lisinopril—Dyspepsia—Prednisone—ankylosing spondylitis	7.13e-05	0.00102	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—ankylosing spondylitis	7.06e-05	0.00101	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—ankylosing spondylitis	7.06e-05	0.00101	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—ankylosing spondylitis	7.06e-05	0.00101	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—ankylosing spondylitis	7.04e-05	0.00101	CcSEcCtD
Lisinopril—Rash—Prednisolone—ankylosing spondylitis	7.02e-05	0.00101	CcSEcCtD
Lisinopril—Dermatitis—Prednisolone—ankylosing spondylitis	7.02e-05	0.001	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	7.01e-05	0.001	CcSEcCtD
Lisinopril—Diarrhoea—Methylprednisolone—ankylosing spondylitis	6.99e-05	0.001	CcSEcCtD
Lisinopril—Fatigue—Prednisone—ankylosing spondylitis	6.98e-05	0.000999	CcSEcCtD
Lisinopril—Headache—Prednisolone—ankylosing spondylitis	6.98e-05	0.000999	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—ankylosing spondylitis	6.97e-05	0.000998	CcSEcCtD
Lisinopril—Constipation—Prednisone—ankylosing spondylitis	6.92e-05	0.000991	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—ankylosing spondylitis	6.82e-05	0.000976	CcSEcCtD
Lisinopril—Dizziness—Triamcinolone—ankylosing spondylitis	6.77e-05	0.00097	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—ankylosing spondylitis	6.77e-05	0.000968	CcSEcCtD
Lisinopril—Dizziness—Methylprednisolone—ankylosing spondylitis	6.76e-05	0.000967	CcSEcCtD
Lisinopril—Infection—Methotrexate—ankylosing spondylitis	6.72e-05	0.000962	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisone—ankylosing spondylitis	6.67e-05	0.000955	CcSEcCtD
Lisinopril—Asthenia—Betamethasone—ankylosing spondylitis	6.67e-05	0.000955	CcSEcCtD
Lisinopril—Asthenia—Dexamethasone—ankylosing spondylitis	6.67e-05	0.000955	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.62e-05	0.000948	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.62e-05	0.000947	CcSEcCtD
Lisinopril—Nausea—Prednisolone—ankylosing spondylitis	6.62e-05	0.000947	CcSEcCtD
Lisinopril—Pruritus—Dexamethasone—ankylosing spondylitis	6.58e-05	0.000941	CcSEcCtD
Lisinopril—Pruritus—Betamethasone—ankylosing spondylitis	6.58e-05	0.000941	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—ankylosing spondylitis	6.57e-05	0.000941	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.54e-05	0.000936	CcSEcCtD
Lisinopril—Vomiting—Triamcinolone—ankylosing spondylitis	6.51e-05	0.000932	CcSEcCtD
Lisinopril—Vomiting—Methylprednisolone—ankylosing spondylitis	6.5e-05	0.00093	CcSEcCtD
Lisinopril—Rash—Triamcinolone—ankylosing spondylitis	6.46e-05	0.000925	CcSEcCtD
Lisinopril—Dermatitis—Triamcinolone—ankylosing spondylitis	6.45e-05	0.000924	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—ankylosing spondylitis	6.45e-05	0.000923	CcSEcCtD
Lisinopril—Rash—Methylprednisolone—ankylosing spondylitis	6.44e-05	0.000922	CcSEcCtD
Lisinopril—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.44e-05	0.000922	CcSEcCtD
Lisinopril—Urticaria—Prednisone—ankylosing spondylitis	6.43e-05	0.00092	CcSEcCtD
Lisinopril—Headache—Triamcinolone—ankylosing spondylitis	6.42e-05	0.000919	CcSEcCtD
Lisinopril—Headache—Methylprednisolone—ankylosing spondylitis	6.4e-05	0.000917	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—ankylosing spondylitis	6.4e-05	0.000916	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—ankylosing spondylitis	6.4e-05	0.000916	CcSEcCtD
Lisinopril—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.36e-05	0.00091	CcSEcCtD
Lisinopril—Diarrhoea—Betamethasone—ankylosing spondylitis	6.36e-05	0.00091	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—ankylosing spondylitis	6.32e-05	0.000905	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.16e-05	0.000882	CcSEcCtD
Lisinopril—Dizziness—Betamethasone—ankylosing spondylitis	6.15e-05	0.00088	CcSEcCtD
Lisinopril—Dizziness—Dexamethasone—ankylosing spondylitis	6.15e-05	0.00088	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—ankylosing spondylitis	6.12e-05	0.000876	CcSEcCtD
Lisinopril—Nausea—Triamcinolone—ankylosing spondylitis	6.09e-05	0.000871	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—ankylosing spondylitis	6.07e-05	0.00087	CcSEcCtD
Lisinopril—Nausea—Methylprednisolone—ankylosing spondylitis	6.07e-05	0.000869	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—ankylosing spondylitis	6.03e-05	0.000863	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—ankylosing spondylitis	6.01e-05	0.000861	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisone—ankylosing spondylitis	5.96e-05	0.000854	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—ankylosing spondylitis	5.96e-05	0.000852	CcSEcCtD
Lisinopril—Vomiting—Betamethasone—ankylosing spondylitis	5.91e-05	0.000846	CcSEcCtD
Lisinopril—Vomiting—Dexamethasone—ankylosing spondylitis	5.91e-05	0.000846	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—ankylosing spondylitis	5.88e-05	0.000842	CcSEcCtD
Lisinopril—Rash—Betamethasone—ankylosing spondylitis	5.86e-05	0.000839	CcSEcCtD
Lisinopril—Rash—Dexamethasone—ankylosing spondylitis	5.86e-05	0.000839	CcSEcCtD
Lisinopril—Dermatitis—Dexamethasone—ankylosing spondylitis	5.86e-05	0.000838	CcSEcCtD
Lisinopril—Dermatitis—Betamethasone—ankylosing spondylitis	5.86e-05	0.000838	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	5.84e-05	0.000836	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—ankylosing spondylitis	5.83e-05	0.000835	CcSEcCtD
Lisinopril—Headache—Dexamethasone—ankylosing spondylitis	5.82e-05	0.000833	CcSEcCtD
Lisinopril—Headache—Betamethasone—ankylosing spondylitis	5.82e-05	0.000833	CcSEcCtD
Lisinopril—Asthenia—Prednisone—ankylosing spondylitis	5.81e-05	0.000831	CcSEcCtD
Lisinopril—Pain—Methotrexate—ankylosing spondylitis	5.79e-05	0.000828	CcSEcCtD
Lisinopril—Pruritus—Prednisone—ankylosing spondylitis	5.73e-05	0.00082	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.58e-05	0.000798	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—ankylosing spondylitis	5.54e-05	0.000793	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.53e-05	0.000792	CcSEcCtD
Lisinopril—Nausea—Dexamethasone—ankylosing spondylitis	5.52e-05	0.00079	CcSEcCtD
Lisinopril—Nausea—Betamethasone—ankylosing spondylitis	5.52e-05	0.00079	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—ankylosing spondylitis	5.37e-05	0.000769	CcSEcCtD
Lisinopril—Dizziness—Prednisone—ankylosing spondylitis	5.35e-05	0.000766	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—ankylosing spondylitis	5.35e-05	0.000765	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—ankylosing spondylitis	5.35e-05	0.000765	CcSEcCtD
Lisinopril—Vomiting—Prednisone—ankylosing spondylitis	5.15e-05	0.000737	CcSEcCtD
Lisinopril—Rash—Prednisone—ankylosing spondylitis	5.1e-05	0.000731	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—ankylosing spondylitis	5.1e-05	0.00073	CcSEcCtD
Lisinopril—Headache—Prednisone—ankylosing spondylitis	5.07e-05	0.000726	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—ankylosing spondylitis	4.98e-05	0.000713	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—ankylosing spondylitis	4.85e-05	0.000695	CcSEcCtD
Lisinopril—Nausea—Prednisone—ankylosing spondylitis	4.81e-05	0.000688	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—ankylosing spondylitis	4.79e-05	0.000685	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—ankylosing spondylitis	4.63e-05	0.000663	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—ankylosing spondylitis	4.47e-05	0.00064	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—ankylosing spondylitis	4.3e-05	0.000616	CcSEcCtD
Lisinopril—Rash—Methotrexate—ankylosing spondylitis	4.27e-05	0.000611	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—ankylosing spondylitis	4.26e-05	0.00061	CcSEcCtD
Lisinopril—Headache—Methotrexate—ankylosing spondylitis	4.24e-05	0.000607	CcSEcCtD
Lisinopril—Nausea—Methotrexate—ankylosing spondylitis	4.02e-05	0.000575	CcSEcCtD
